Younghoon Kim
Papers
1
Total Citations
99
H-Index
1
About
Younghoon Kim is a pioneering researcher in infectious disease biology and drug discovery, with a primary focus on host–pathogen interactions and antimicrobial resistance. His most cited work, “Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus” (2014, 99 citations), introduced a groundbreaking high-throughput screening system using the nematode *Caenorhabditis elegans* as a whole-animal infection model. By adapting the *C. elegans*–*S. aureus* assay from solid agar to liquid format, Kim enabled automated, real-time monitoring of infection and drug efficacy, dramatically accelerating the discovery of novel therapeutics against multidrug-resistant pathogens. This platform represents a major contribution to the field, bridging the gap between in vitro assays and mammalian models. Kim’s research has profound implications for combating hospital-acquired infections, particularly those caused by methicillin-resistant *Staphylococcus aureus* (MRSA). His work is widely cited for its innovation in whole-animal screening and its potential to reduce the global burden of antimicrobial resistance.
Research Focus
Key Achievements
Top Papers
- 1